[Long-Term Survivor with Recurrent Gastric Cancer Using Trifluridine/Tipiracil as a Late-Line Chemotherapy]

Satoshi Hamada1, Shuhei Komatsu, Rie Shibata

  • 1Dept. of Surgery, Kyoto First Red Cross Hospital.